V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003913 | 330001955 | 1.72 | 67.3 | Curative (C) | 2015-06-21 | 2015-06-26 | Cetuximab + Radiotherapy Maint | 02 | Y | 330014870 | CETUXIMAB + RT |
| 330003914 | 330001956 | 1.7 | 19.5 | Palliative (P) | 2015-08-30 | 2015-09-01 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330014875 | CISPLATIN + GEMCITABINE |
| 330003915 | 330001956 | 1.74 | 67.6 | Neo-adjuvant (N) | 2014-11-28 | 2014-12-11 | EW EuroEwing 2012 Arm A VIDE | N | N | 330014875 | EURO-EWING |
| 330003916 | 330001956 | 1.79 | 69.8 | Neo-adjuvant (N) | 2015-08-23 | 2015-09-04 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330014875 | CARBO + FLUOROURACIL |
| 330003917 | 330011359 | 0 | 86.7 | Adjuvant (A) | 2015-04-23 | 2015-05-06 | CISPLATIN + GEMCITABINE | N | N | 330014883 | CISPLATIN + GEMCITABINE |
| 330003918 | 330001957 | 1.68 | 75.3 | Adjuvant (A) | 2013-12-04 | 2013-12-07 | MAP | N | Y | 330014884 | MAP |
| 330003919 | 330001957 | 1.64 | 54.7 | Neo-adjuvant (N) | 2015-01-20 | 2015-01-27 | EURAMOS TRIAL | 02 | N | 330014884 | EURAMOS TRIAL |
| 330003920 | 330001958 | 1.64 | 80.8 | Neo-adjuvant (N) | 2013-08-01 | 2013-08-08 | Dox + HD Mtx (post PAM) | 2 | N | 330014897 | DOXORUBICIN + HD MTX |
| 330003921 | 330001959 | 1.68 | 47.9 | Curative (C) | 2014-11-05 | 2014-11-18 | MAP | 2 | N | 330014905 | MAP |
| 330003922 | 330001959 | 1.73 | 68.6 | Curative (C) | 2013-10-29 | 2013-11-12 | CETUXIMAB + RT | 2 | N | 330014905 | CETUXIMAB + RT |
| 330003923 | 330001960 | 1.6 | 102.9 | Neo-adjuvant (N) | 2015-11-15 | 2015-11-15 | EW EuroEwing 99 : VIDE | N | N | 330014923 | EURO-EWING |
| 330003924 | 330001961 | 0 | 68.9 | Curative (C) | 2014-09-01 | 2014-09-11 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 330014928 | EURO-EWING |
| 330003925 | 330001961 | 0 | 81.8 | Palliative (P) | 2014-04-18 | 2014-04-30 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | N | N | 330014928 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003926 | 330001961 | 1.4 | 46.8 | Curative (C) | 2017-05-27 | 2017-07-06 | Cetuximab + Radiotherapy Maint | 02 | Y | 330014928 | CETUXIMAB + RT |
| 330003927 | 330001961 | 1.79 | null | Curative (C) | 2014-05-10 | 2014-05-22 | CETUXIMAB + RT | 2 | N | 330014928 | CETUXIMAB + RT |
| 330003928 | 330001962 | 1.62 | 64.4 | Disease modification (D) | 2015-04-28 | 2015-05-14 | Cyclophosphamide + Dex + Rituximab | N | Y | 330014950 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003929 | 330001963 | 1.74 | 76.2 | Neo-adjuvant (N) | 2015-02-28 | 2015-03-11 | MAP | N | N | 330014951 | MAP |
| 330003930 | 330001963 | 1.74 | 74 | Curative (C) | 2015-04-03 | 2015-04-09 | EURAMOS TRIAL | Y | N | 330014951 | EURAMOS TRIAL |
| 330003932 | 330007069 | 1.6 | 61 | Adjuvant (A) | 2017-03-30 | 2017-04-04 | DA 3+8 | 2 | N | 330014960 | DA |
| 330003933 | 330007069 | 1.57 | 76.7 | Curative (C) | 2013-05-11 | 2013-05-19 | DA 3 + 10 | 2 | N | 330014960 | DA |
| 330003934 | 330001965 | 1.47 | 48.2 | Curative (C) | 2014-07-25 | 2014-07-25 | EW EuroEwing 2012 Arm A VIDE | N | N | 330014973 | EURO-EWING |
| 330003935 | 330001965 | 1.83 | 69.6 | Adjuvant (A) | 2016-01-01 | 2016-01-03 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 330014973 | CISPLATIN + GEMCITABINE |
| 330003939 | 330001967 | 1.62 | 81.05 | Not known (9) | 2013-05-04 | 2013-05-23 | Cetuximab + Radiotherapy Load | N | N | 330015028 | CETUXIMAB + RT |
| 330003940 | 330007072 | 1.54 | 110 | Curative (C) | 2013-11-24 | 2013-12-16 | EW EuroEwing 2012 Arm A VIDE | N | Y | 330015043 | EURO-EWING |
| 330003941 | 330007072 | 1.77 | 92.8 | Palliative (P) | null | 2018-01-28 | Cyclophosphamide + Dex + Rituximab | null | null | 330015043 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003942 | 330011361 | 0 | null | Adjuvant (A) | null | 2013-04-03 | CVP R | null | null | 330015057 | CVP R |
| 330003943 | 330011361 | 1.54 | 88.3 | Curative (C) | 2014-05-14 | 2014-05-14 | CETUXIMAB | 02 | N | 330015057 | CETUXIMAB |
| 330003944 | 330001968 | 1.8 | 92.2 | Neo-adjuvant (N) | null | 2015-12-09 | Carboplatin+Fluorouracil 4 or 5 day | null | null | 330015068 | CARBO + FLUOROURACIL |
| 330003946 | 330009828 | null | null | null | 2016-08-06 | 2016-08-15 | Carbo F | N | N | 330015072 | CARBO + FLUOROURACIL |
| 330003947 | 330001969 | 1.83 | 70.3 | Curative (C) | 2015-11-30 | 2015-12-10 | OST Euramos 1 Closed Trial - AP | 02 | N | 330015077 | MAP |
| 330003948 | 330001970 | null | 54.7 | Palliative (P) | 2017-01-19 | 2017-01-20 | CARBOPLATIN + GEMCITABINE | N | null | 330015089 | GEMCARBO |
| 330003949 | 330001971 | 1.83 | 20.4 | Curative (C) | 2016-02-13 | 2016-02-19 | DA | N | N | 330015103 | DA |
| 330003950 | 330001971 | 1.75 | 118 | Disease modification (D) | null | 2017-04-03 | Cyclophosphamide + Dex + Rituximab | null | null | 330015103 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003951 | 330001971 | 1.79 | 50.4 | Neo-adjuvant (N) | 2015-03-30 | 2015-05-27 | EW EuroEwing 2012 Arm A VIDE | null | Y | 330015103 | EURO-EWING |
| 330003952 | 330001972 | null | 76.3 | Disease modification (D) | 2013-07-30 | 2013-07-30 | CVP R | N | N | 330015115 | CVP R |
| 330003953 | 330007075 | 1.8 | 57 | Neo-adjuvant (N) | 2013-02-06 | 2013-02-06 | EURAMOS TRIAL | 02 | N | 330015116 | EURAMOS TRIAL |
| 330003954 | 330007075 | 1.46 | 84 | Curative (C) | 2017-02-04 | 2017-02-09 | DA 3 + 10 | N | N | 330015116 | DA |
| 330003957 | 330001974 | null | 28.6 | Palliative (P) | 2016-08-12 | 2016-08-19 | CARBOPLATIN + GEMCITABINE | N | N | 330015129 | GEMCARBO |
| 330003958 | 330001975 | 1.75 | 72.5 | Neo-adjuvant (N) | 2015-09-26 | 2015-09-29 | MAP | N | N | 330015133 | MAP |
| 330003959 | 330001975 | 0 | 104.8 | Adjuvant (A) | 2014-08-06 | 2014-08-06 | Cetuximab + Radiotherapy Maint | Y | Y | 330015133 | CETUXIMAB + RT |
| 330003960 | 330001976 | 1.77 | 70.4 | Neo-adjuvant (N) | 2013-03-24 | 2013-03-25 | CVP R | 02 | null | 330015137 | CVP R |
| 330003961 | 330001977 | 1.75 | 69 | null | 2016-10-29 | 2016-11-13 | CETUXIMAB | 02 | Y | 330015146 | CETUXIMAB |
| 330003962 | 330001977 | 1.67 | 48.2 | Curative (C) | 2014-05-31 | 2014-05-31 | Dox + HD Mtx (post PAM) | 02 | N | 330015146 | DOXORUBICIN + HD MTX |
| 330003963 | 330001977 | 1.66 | 76.3 | Palliative (P) | 2016-06-30 | 2016-06-30 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 330015146 | CARBO + FLUOROURACIL |
| 330003964 | 330001977 | null | 105 | Disease modification (D) | 2016-02-19 | 2016-02-19 | CVP R | 02 | null | 330015146 | CVP R |
| 330003965 | 330001977 | 1.66 | 16.4 | Disease modification (D) | 2015-06-17 | 2015-06-26 | Cyclophosphamide + Dex + Rituximab | N | N | 330015146 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003966 | 330001978 | 1.59 | 64 | Neo-adjuvant (N) | 2013-09-14 | 2013-09-22 | Dox + HD Mtx (post PAM) | 02 | N | 330015195 | DOXORUBICIN + HD MTX |
| 330003967 | 330001979 | 1.84 | 75.2 | Curative (C) | 2016-02-10 | 2016-02-17 | EURAMOS TRIAL | N | N | 330015196 | EURAMOS TRIAL |
| 330003968 | 330001980 | 1.61 | 60.7 | Curative (C) | 2014-04-30 | 2014-05-08 | CAP | N | N | 330015204 | CAP |
| 330003969 | 330001980 | -1 | 50.9 | Neo-adjuvant (N) | 2017-12-11 | 2017-12-16 | Dox + HD Mtx (post PAM) | N | N | 330015204 | DOXORUBICIN + HD MTX |